FIS (Fabbrica Italiana Sintetici)

Montecchio Maggiore (Vicenza), Italywww.fisvi.com1expert edge

Leading European CDMO specializing in small-molecule APIs and intermediates, founded in 1957. Operates three manufacturing sites in Italy with 1,800+ employees and FDA-inspected facilities. Controlled by Bain Capital following 2023 acquisition.

Why interesting to a deal team

Connected investor co-led 2023 acquisition; Bain Capital ownership combined with European API/CDMO leadership makes this a core portfolio asset for pharma services expansion.

Experts connected to this company

Christina DixCo-led 2023 acquisition of Italian API/CDMO manufacturer

Christina Dix

Partner, European Private Equity Healthcare

Bain Capital

Fund GPLondon

Co-heads Bain Capital's European healthcare practice and is actively deploying capital into pharma services and CDMO assets like PCI Pharma and FIS.

Sources

Name + firmPrimaryArchived 2026-04-10
fisvi.com/en/our-site
No name matchOtherBot-blocked
cphi-online.com/company/f-i-s-fabbrica-italiana-sintetici-s-p-a
No name matchPrimary
fisvi.com

Strongest evidenceName + firm3 public sourcesHow the grades work